ENLIVEN THERAPEUTICS, INC. Convertible Preferred Stock, Shares Issued upon Conversion
ENLIVEN THERAPEUTICS, INC. (ELVN) had Convertible Preferred Stock, Shares Issued upon Conversion of 0 shares as of 2023-12-31, per its 10-K filed 2024-03-14.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2025-03-13
- 2023-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 0.00 shares.
- 2023-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 0.00 shares.
- 2023-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 0.00 shares.
- 2023-02-23: Convertible Preferred Stock, Shares Issued upon Conversion 18.22M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2023-12-31 | 0.00 shares 10-K · filed 2024-03-14 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-10 |
| 2023-02-23 | 18.22M shares 10-K · filed 2025-03-13 |
| 2022-12-31 | 18.22M shares 10-K · filed 2024-03-14 |
| 2021-12-31 | 18.22M shares 8-K · filed 2023-06-23 |
| 2020-03-16 | 11.17M shares 10-K · filed 2022-03-15 |
| 2019-12-31 | 9.61M shares 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |